| 骨髓增生异常综合征最新研究进展:第56届美国血液学会年会报道 |
| |
| 引用本文： | 刘平,陈宝安. 骨髓增生异常综合征最新研究进展:第56届美国血液学会年会报道[J]. 白血病．淋巴瘤, 2015, 24(1): 43-45. DOI: 10.3760/cma.j.issn.1009-9921.2015.01.013 |
| |
| 作者姓名： | 刘平 陈宝安 |
| |
| 作者单位： | 东南大学医学院中大医院血液科江苏省医学重点学科东南大学MDS研究所,南京,210009 |
| |
| 摘 要： | 骨髓增生异常综合征(MDS)是一组起源于造血干/祖细胞水平损伤而产生的获得性克隆性疾病,以无效造血和易转化为急性白血病为特点.第56届美国血液学会(ASH)年会报道了大量MDS的相关发病机制及对患者预后、指导用药意义的研究,并就不同MDS的药物治疗及造血干细胞移植等方面做了详尽报道.
|
| 关 键 词： | 骨髓增生异常综合征 发病机制 治疗 美国血液学会年会 |
Recent progress of myelodysplastic syndrome: reports from the 56th American Society of Hematology annual meeting |
| |
| Liu Ping,Chen Baoan. Recent progress of myelodysplastic syndrome: reports from the 56th American Society of Hematology annual meeting[J]. Journal of Leukemia & Lymphoma, 2015, 24(1): 43-45. DOI: 10.3760/cma.j.issn.1009-9921.2015.01.013 |
| |
| Authors: | Liu Ping Chen Baoan |
| |
| Abstract: | The myelodysplastic syndromes (MDS),which are characterized by the presence of ineffective hematopoiesis and an increased risk of transformation to acute myeloid leukemia (AML),are a group of clonal disorders deriving from damage of the hematopoietic stem/progenitor cells.In the 56th American Society of Hematology (ASH) annual meeting,lots of new discoveries about the pathogenesis of MDS and the role of the pathogenesis in the clinical outcomes and treatment were introduced.There were also many developments in the treatment of MDS including drug therapies and Hematopoietic stem cell tranplantation (HSCT) reported in the meeting. |
| |
| Keywords: | Myelodysplastic syndromes Pathogenesis Treatment American Society of Hematology annual meeting |
| 本文献已被 万方数据 等数据库收录！ |
